ArticleBMC cancer2022

Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer.

G Sommerhäuser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.